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Abstract
Background: Chlamydiales are familiar causes of acute and chronic infections in humans and animals. Human pulmonary
emphysema is a component of chronic obstructive pulmonary disease (COPD) and a condition in which chronic inflammation
manifested as bronchiolitis and intra-alveolar accumulation of macrophages is common. It is generally presumed to be of
infectious origin. Previous investigations based on serology and immunohistochemistry indicated Chlamydophila pneumoniae
infection in cases of COPD. Furthermore, immunofluorescence with genus-specific antibodies and electron microscopy
suggested involvement of chlamydial infection in most cases of pulmonary emphysema, but these findings could not be verified
by PCR. Therefore, we examined the possibility of other chlamydial species being present in these patients.
Methods: Tissue samples from patients having undergone lung volume reduction surgery for advanced alpha-1 antitrypsin
deficiency (AATD, n = 6) or non-alpha-1 antitrypsin deficiency emphysema (n = 34) or wedge resection for hamartochondroma
(n = 14) were examined by transmission electron microscopy and PCR.
Results: In all cases of AATD and 79.4% of non-AATD, persistent chlamydial infection was detected by ultrastructural
examination. Intra-alveolar accumulation of macrophages and acute as well as chronic bronchiolitis were seen in all positive
cases. The presence of Chlamydia psittaci was demonstrated by PCR in lung tissue of 66.7% AATD vs. 29.0% non-AATD
emphysema patients. Partial DNA sequencing of four positive samples confirmed the identity of the agent as Chlamydophila
psittaci. In contrast, Chlamydophila pneumoniae was detected only in one AATD patient. Lung tissue of the control group of non-
smokers with hamartochondroma was completely negative for chlamydial bodies by TEM or chlamydial DNA by PCR.
Conclusions: These data indicate a role of Chlamydophila psittaci in pulmonary emphysema by linking this chronic inflammatory
process to a chronic infectious condition. This raises interesting questions on pathogenesis and source of infection.
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Background
Several species of the family Chlamydiaceae  are well-
known etiological agents of acute and chronic infections
in humans and animals [1,2]. The first description of
chlamydial respiratory disease in humans referred to psit-
tacosis, also known as ornithosis, and dates back to 1879
[3]. Chlamydia (C.) psittaci, the agent responsible for this
disease, has had several different names and, according to
a recent proposal, should now be called Chlamydophila
(Cp.) psittaci [4]. A century later, in 1986, Grayston et al.
discovered another chlamydial respiratory agent, strain
TWAR, which was later assigned to the species C. pneumo-
niae [5,6] currently reclassified as Chlamydophila pneumo-
niae [4]. Meanwhile, a variety of respiratory conditions in
humans has been shown to be associated with this agent.
Evidence of Cp. pneumoniae infection based on serology
was reported in severe cases of chronic obstructive pulmo-
nary disease (COPD), in which emphysema is dominant
[7,8], as well as in exacerbations of COPD [9] and in per-
sistent infections of the respiratory tract [10,11]. The
detection rate of Cp. pneumoniae by immunohistochemi-
cal staining was elevated in lung tissue from subjects with
COPD, but controls were not completely negative [12].
Initially Cp. pneumoniae was thought to be virulent for
humans only, but recent descriptions of isolates from
horse, koala, frog and reptiles suggest a wider host spec-
trum and even the possibility of zoonotic transmission
[13-15].
Our previous investigations by means of immunofluores-
cence using a genus-specific antiserum against chlamydial
LPS and scanning as well as transmission electron micro-
scopy showed infection of the alveolar parenchyma and
the bronchioles by Chlamydia spp. in patients having
undergone lung volume reduction surgery for advanced
pulmonary emphysema [16,17]. Accumulation of alveo-
lar macrophages as well as different forms of bronchiolitis
and focal pneumonia accompanying emphysematic
changes were found regularly [18]. In preliminary exami-
nations using an established nested PCR with DNA
hybridization [19], DNA specific of Cp. pneumoniae was
detected in two out of ten cases [20]. But this detection
rate was far lower than that in electron microscopy or
immunofluorescence using genus-specific antibodies,
which showed Chlamydia spp. in over 80% [17]. Because
of this fact PCR was extended to other Chlamydiaceae. Here
we report the results of a more detailed study involving a
larger number of cases and samples including controls.
Methods
Samples
Lung tissue of adequate quality from patients with
advanced emphysema undergoing lung volume reduction
surgery was used for the present study [18,21]. Samples
examined by transmission electron microscopy (TEM)
included five specimens from alpha-1 antitrypsin defi-
ciency (AATD) and 34 from non-AATD patients. PCR
examinations were conducted on six AATD and 31 non-
AATD specimens. History showed a status of cigarette
smoking with over ten packyears in most of these patients
(91.7%). There were two non-smokers among nine
patients with AATD. Furthermore patients with hamarto-
chondroma undergoing wedge resection were reviewed
for clinical data (A.M.) and histology. Normal lung tissue
of 14 non-smokers taken with resection of hamartochon-
droma was selected as a control group. Statistical analysis
was done using SPSS, version 11.5 (SPSS Inc., Chicago,
USA) on a PC running Windows XP Professional (Micro-
soft, Redmond, USA) as operating system. A test value
below 0.05 was considered to be statistically significant.
Light Microscopy and Transmission Electron Microscopy 
(TEM)
Formalin-fixed lung tissue was embedded in paraffin wax
(Tissuewax™; Medite GmbH, Burgdorf, Germany), slides
of 3–7 µm thickness were cut using a rotatory microtome
(Microm GmbH, Walldorf, Germany) and stained by
hematoxylin and eosin. For TEM, tissue was fixed in 2.5%
buffered glutaraldehyde or 3.5% formaldehyde and
embedded in epon after postfixation with osmium tetrox-
ide and block contrastation with uranyl acetate. In the
cases of the hamartochrondroma control group, cores
with diameters of 0.60 cm and 0.24 cm were obtained
from paraffin blocks using a prototypical self-made man-
ual tissue puncher (a device for tissue microarray con-
struction developed by M.W.). These cores were used to
select an area well defined by light microscopy for PCR
(0.60 cm cores) and TEM (0.24 cm cores). For TEM, tissue
was dewaxed with xylene and processed as described
above. Semithin sections (prepared on a Reichert Om U3
ultramicrotome; Reichert, Vienna, Austria) were stained
with basic fuchsin and methylene blue to define blocks of
adequate quality. Ultrathin sections from two to five
blocks were stained with lead citrate and examined using
a Zeiss EM 900 transmission electron microscope (Zeiss,
Oberkochen, Germany).
Polymerase Chain Reaction (PCR)
Tissue from two different resources was used. Firstly, fro-
zen tissue was collected immediately after resection and
stored at -80°C (n = 31). Secondly, paraffin-embedded
tissue (PET) containing histologically discernible inflam-
mation sites was used, and sections or 0.60 cm cores were
dewaxed using xylene (n = 12 and 14 controls). In five
cases, material was available as both frozen and PET. DNA
was isolated from lung tissue using the High Pure PCR
Template Preparation Kit (Roche Diagnostics, Mannheim,
Germany) according to the instructions of the manufac-
turer. Five µl of the DNA extract were used as template in
PCR.BMC Infectious Diseases 2004, 4:38 http://www.biomedcentral.com/1471-2334/4/38
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Samples were tested forC. psittaci and Cp. pneumoniae by a
modified version of the nested PCR procedure described
by Kaltenböck et al. [22], which targets the ompA gene. The
first step was genus-specific amplification using primers
191CHOMP (5'-GCI YTI TGG GAR TGY GGI TGY GCI
AC-3') and CHOMP371 (5'-TTA GAA ICK GAA TTG IGC
RTT IAY GTG IGC IGC-3'). For the second amplification,
we used 1 µl of the genus-specific product and primer
combination 218PSITT (5'-GTA ATT TCI AGC CCA GCA
CAA TTY GTG-3') / CHOMP336s (5'-CCR CAA GMT TTT
CTR GAY TTC AWY TTG TTR AT-3') for C. psittaci, or
201CHOMP (5'-GGI GCW GMI TTC CAA TAY GCI CAR
TC-3') / PNEUM268 (5'-GTA CTC CAA TGT ATG GCA
CTA AAG A-3'), for Cp. pneumoniae, respectively. The sizes
of specific amplicons are: 576–597 bp (genus-specific
product), and 389–404 bp for C. psittaci or 244 bp for Cp.
pneumoniae after nested PCR. A detailed protocol of the
procedure is contained in [23].
Histology of alpha-1 antitrypsin deficiency emphysema Figure 1
Histology of alpha-1 antitrypsin deficiency emphy-
sema. In alpha-1 antitrypsin deficiency, advanced panacinar 
destruction of the lung parenchyma and accumulation of 
macrophages (A, hematoxylin eosin, original magnification 
×40), as well as severe acute and chronic bronchiolitis are 
seen (B, periodic acid Schiff's reaction, original magnification 
×100).
Histology of non-alpha-1 antitrypsin deficiency emphysema Figure 2
Histology of non-alpha-1 antitrypsin deficiency 
emphysema. In non-alpha-1 antitrypsin deficiency emphy-
sema, chronic respiratory bronchiolitis, destruction of the 
alveolar architecture, prominent accumulation of macro-
phages (A, hematoxylin eosin, original magnification ×40) and 
marked bronchiolitis of the terminal bronchioles is found (B, 
hematoxylin eosin, original magnification ×100).BMC Infectious Diseases 2004, 4:38 http://www.biomedcentral.com/1471-2334/4/38
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DNA sequencing
In order to discriminate the different members of the C.
psittaci-group [4], five µl of the final DNA extract served as
template for PCR amplification of the 16S rRNA signature
region. Amplicon bands were cut out of agarose gels,
extracted using the QIAquick Gel Extraction Kit (QIAGEN,
Hilden, Germany), and subjected to cycle sequencing
using the BigDye™ Terminator Cycle Sequencing Ready
Reaction Kit (Applied Biosystems, Darmstadt, Germany).
The oligonucleotides 16SIGF (5'-CCG CGT GGA TGA
GGC AT-3') and 16SIGR (5'-TCA GTC CCA GTG TTG GC-
3') were used as amplification and sequencing primers
[4]. Nucleotide sequences were determined on an ABI
Prism 310 Genetic Analyzer (Applied Biosystems).
Results
Light microscopy
The median value of age was 46.5 in AATD, 58.0 in non-
AATD emphysema and 64.5 in hamartochondroma. The
rate of females varied between 33.3% in AATD, 37.5% in
non-AATD and 42.9% in hamartochondroma. Histology
revealed destruction of the alveoli, intra-alveolar accumu-
lation of macrophages, and acute alongside chronic bron-
chiolitis in all cases of AATD (Fig. 1A,1B) and non-AATD
emphysema (Fig. 2A,2B) consistent with previous exami-
nations. In cases of hamartochondroma only some mac-
rophages and mucus in the bronchioli could be detected
(Fig. 3).
Transmission electron microscopy
TEM images illustrate that the cell and tissue morphology
appeared severely destroyed in emphysema samples.
Chlamydial elementary and reticular bodies of 0.2 to 0.8
µm diameter were found on the surface of alveolar or
bronchiolar epithelium and showed adherence to micro-
villi as previously described [16,17]. Reticular and some
elementary bodies were seen in AATD (Fig. 4) and non-
AATD emphysema (Fig. 5A,5B,5C), they were scattered
within the interstitium (Fig. 5A) and also assembled in
groups (Fig. 5B). Perinuclear inclusions could be detected
in fibroblasts (Fig. 5C). Altogether, in 32 cases (82%) typ-
ical morphological structures indicating persistent
chlamydial infection were present. In seven cases of
emphysema, chlamydial bodies could not be detected or
the findings were ambiguous. Detection rates were higher
in AATD emphysema (5/5 = 100%) than in non-AATD
emphysema (27/34 = 79.4%, Table 1). The control group
of patients with hamartochondroma showed no signs of
chlamydial infection in TEM.
Polymerase Chain Reaction (PCR)
Examination by PCR revealed the presence of C. psittaci-
specific DNA in four (66.7%) specimens with AATD and
nine (29%) with non-AATD emphysema (Fig. 6, Table 1).
In one case of AATD, the amplicon was identified as Cp.
pneumoniae. PCR was negative in all cases with hamarto-
chondroma. The detection rate for C. psittaci in emphyse-
matic tissue was higher from PET than from frozen
Histology of normal lung tissue in patients with  hamartochondroma Figure 3
Histology of normal lung tissue in patients with 
hamartochondroma. In cases of hamartochondroma, only 
some macrophages and mucus can be detected in the bron-
chioli (hematoxylin eosin, original magnification ×15). No 
signs for emphysema or bronchiolitis could be detected.
Transmission electron microscopy of alpha-1 antitrypsin defi- ciency emphysema Figure 4
Transmission electron microscopy of alpha-1 antit-
rypsin deficiency emphysema. Chlamydial bodies 
(arrows) and destruction of the interstitial connective tissue 
are seen in alpha-1 antitrypsin deficiency. Ultrastructure is 
less well preserved after fixation in formaldehyde.BMC Infectious Diseases 2004, 4:38 http://www.biomedcentral.com/1471-2334/4/38
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material (50% vs. 21.9%, Fisher Yates test n. s.). In five
cases, where both PET and frozen tissue were examined,
one patient was positive in TEM and another one in PCR.
DNA sequencing
To confirm the identity of the chlamydial species, DNA
from four of the positive samples, i.e. N16, N25, N26, and
N33, was sequenced in the 16S rRNA signature region
(approximately 300 bp, Fig. 7). A BLAST search of these
sequences revealed close to 100 % homology to the spe-
cies Cp. psittaci.
Discussion
Strains of Cp. psittaci are known to cause infections in over
130 avian species and 32 other domestic and wild
animals. Classical psittacosis represents a systemic disease
in psittacine birds of acute, protracted, chronic or subclin-
ical manifestation. Avian strains of the agent are known to
be pathogenic to humans, the symptoms being mainly
non-specific and influenza-like, but severe pneumonia,
endocarditis and encephalitis are not uncommon [24,25].
The possibility of persistent infection in man was first
described in the 1950s [26].
In the present study and in previous investigations, trans-
mission electron microscopy revealed elementary bodies
as well as typical and aberrant reticular bodies, thus
indicating active infection alongside persistent infection
[10,16,17]. Chlamydiae could not be detected in each
case, but the rate of positive findings in TEM and PCR
(Table 1) was comparable to that of Cp. pneumoniae in
atherosclerosis [27,28]. Pear-shaped elementary bodies as
typically found in Cp. pneumoniae infection [29] were not
observed. While the findings of TEM are more indicative
of Cp. psittaci infection [30], it must be noted that this
method provides no clear-cut differentiation among
Chlamydiaceae species, for even strains of the same species
exhibit different morphology at the various developmen-
tal stages. Rather unexpectedly, Cp. pneumoniae was
detected only in one sample by PCR, not indicating an
important role of this agent in the cases examined here.
The fact that, apart from psittacosis, Cp. psittaci has not
been associated with human respiratory disorders in
recent decades may be a question of sensitivity and specif-
icity of detection. Particularly PCR with its capability to
specifically identify all individual species of Chlamydiaceae
at a detection limit of less than one inclusion-forming
unit has opened up new possibilities in this respect.
Higher detection rates of Cp. psittaci in tissue with histo-
logical evidence of inflammation in comparison to unse-
lected frozen tissue (6/12 = 50% vs. 7/32 = 21.9%, Fisher
Yates test n.s.) indicate an association with regional activ-
ity of infection and inflammation. Besides psittacosis, Cp.
psittaci  has been recently associated with chronic
inflammation in patients with ocular adnexal lymphomas
[31]. In COPD, activated macrophages and neutrophils
produce matrix metalloproteinases which are relevant in
the development of emphysema [32,33]. The release of
matrix metalloproteinases was shown to be stimulated by
cytokines produced in the course of chlamydial infection
[34] and by chlamydial heat shock protein 60 as well [35].
These findings represent a link to the established pathoge-
netic concepts in pulmonary emphysema. Cp. psittaci was
found at comparable and statistically significant rates in
AATD and non AATD emphysema.
Conclusions
The fact that the chlamydial agent present in the emphy-
sema tissue was identified by DNA sequencing as an avian
serovar of Cp. psittaci provides an important indication on
the source of infection. It is conceivable that the patients
were infected through contact with birds, although this
could not be verified for lack of relevant data on history.
The detection rate of chlamydiae in cases of AATD emphy-
sema vs. non-AATD emphysema was clearly higher, thus
indicating a relevant role of Cp. psittaci infection in this
disorder, or at least a higher susceptibility of AATD
Table 1: Detection of Chlamydia spp. in emphysema by TEM and PCR
Groups Cases C. psittaci C. pneumoniae Fisher Yates test vs. controls
AATD emphysema
TEM 5 5 (100%) 0.00009
PCR 6 4 (66.7%) 1 (16.7%) 0.00310*
Non AATD emphysema
TEM 34 27 (79.4%) 0.00000
PCR 31 9 (29.0%) 0 (0%) 0.03989
Controls
TEM 14 0 (0%)
PCR 14 0 (0%) 0 (0%)
AATD = alpha-1 antitrypsin deficiency, * = for C. psittaci onlyBMC Infectious Diseases 2004, 4:38 http://www.biomedcentral.com/1471-2334/4/38
Page 6 of 8
(page number not for citation purposes)
patients for an infection of their lungs with Cp. psittaci.
Further investigations concerning smokers and non-
smokers, pathogenetic relevance and zoonotic implica-
tions are required. In any circumstances, Cp. psittaci has to
be considered an underestimated pathogen with consider-
able importance in public health, although the various
facets of its specific impact have yet to be evaluated.
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